GSK PLC Director/PDMR Shareholding (2738T)
2023年11月14日 - 12:30AM
RNSを含む英国規制内ニュース (英語)
TIDMGSK
RNS Number : 2738T
GSK PLC
13 November 2023
GSK plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Emma Walmsley
=== ============================ =====================================================
b) Position/status Chief Executive Officer
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 9 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Julie Brown
=== ============================ =====================================================
b) Position/status Chief Financial Officer
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 9 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name James Ford
=== ============================ =====================================================
b) Position/status SVP and Group General Counsel, Legal and
Compliance
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 9 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Sally Jackson
=== ============================ =====================================================
b) Position/status SVP, Global Communications and CEO Office
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 9 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name David Redfern
=== ============================ =====================================================
b) Position/status President Corporate Development
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 9 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Regis Simard
=== ============================ =====================================================
b) Position/status President, Global Supply Chain
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 8 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 8 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 16 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Phil Thomson
=== ============================ =====================================================
b) Position/status President, Global Affairs
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 9 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Deborah Waterhouse
=== ============================ =====================================================
b) Position/status CEO, ViiV Healthcare and President, Global
Health, GSK
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 8 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 8 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 16 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
=== ===================================================================================
a) Name Victoria Whyte
=== ============================ =====================================================
b) Position/status Company Secretary
=== ============================ =====================================================
c) Initial notification/ Initial notification
amendment
=== ============================ =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== ===================================================================================
a) Name GSK plc
=== ============================ =====================================================
b) LEI 5493000HZTVUYLO1D793
=== ============================ =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== ===================================================================================
a) Description of Ordinary shares of 31 1/4 pence each ('Ordinary
the financial Shares')
instrument ISIN: GB00BN7SWP63
=== ============================ =====================================================
b) Nature of the Acquisition of Ordinary Shares under the
transaction Company's Share Reward Plan
=== ============================ =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
=== ============================ ================ ===============================
GBP14.2325 9 (partnership shares)
=== ============================ ================ ===============================
GBP14.2325 9 (matching shares)
================ ===============================
d) Aggregated information
===
Aggregated volume 18 Ordinary Shares
Price GBP 14.2325
=== ============================ =====================================================
e) Date of the transaction 2023-11-09
=== ============================ =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
=== ============================ =====================================================
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFFIFDDEDSELF
(END) Dow Jones Newswires
November 13, 2023 10:30 ET (15:30 GMT)
Gsk (LSE:GSK)
過去 株価チャート
から 6 2024 まで 7 2024
Gsk (LSE:GSK)
過去 株価チャート
から 7 2023 まで 7 2024